Skip to main navigation
Hookipa Pharma
To reprogram the immune system to help overcome cancer and infectious diseases.
Live - Corporate & Investor Relations
Our Company
About Us
HOOKIPA Values
Our People
Leadership
Executives
Board of Directors
CMC Board
Scientific Advisory Board
Founders
Our Science
Our Arenavirus Platform
Our Technologies
Scientific Publications
Our Programs
Our Pipeline
Infectious Diseases
Immuno-Oncology
Partnering
Patients & Caregivers
Our Clinical Trials
Expanded Access
Investors & Media
Press Releases
Events
Presentations
Annual Reports
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
FAQs
Email Alerts
Contact
Careers
Home
Investor Relations
Events
HB-200 Data Update
Events
HB-200 Data Update
Jun 1, 2023 at 8:00 AM EDT
Webcast